NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

NextPlat Corp. (NASDAQ:NXPL) was the recipient of a large growth in short interest in September. As of September 30th, there was short interest totaling 189,800 shares, a growth of 216.3% from the September 15th total of 60,000 shares. Currently, 1.4% of the company’s stock are sold short. Based on an average daily volume of 128,300 shares, the short-interest ratio is currently 1.5 days. Based on an average daily volume of 128,300 shares, the short-interest ratio is currently 1.5 days. Currently, 1.4% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of NextPlat in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

NextPlat Price Performance

Shares of NASDAQ NXPL opened at $0.72 on Monday. NextPlat has a twelve month low of $0.43 and a twelve month high of $2.30. The stock’s 50 day moving average price is $0.77 and its 200-day moving average price is $0.70. The company has a market capitalization of $18.74 million, a PE ratio of -1.64 and a beta of 1.05. The company has a quick ratio of 3.49, a current ratio of 4.33 and a debt-to-equity ratio of 0.05.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.